AKR1B10 and glioblastoma: As shown in Figure 9, the increased AKR1B10 expression was significantly related to poor overall survival (OS) in GBM, THCA, UVM, SKCM, MESO, LIHC, PAAD, KICH, KIRC, KIRP, and PRAD, but better OS in ACC, COAD, and READ.